Recombinant Bovine Tissue factor (F3)

What is Recombinant Bovine Tissue Factor (F3) and how does it function in biological systems?

Recombinant Bovine Tissue Factor (F3) is a cell surface glycoprotein that functions as both a receptor and an enzyme, playing a pivotal role in the coagulation cascade and the extrinsic pathway of blood clotting. It is primarily expressed on the surface of various cells including endothelial cells, monocytes, and fibroblasts . In bovine systems, F3 is crucial for maintaining hemostasis and preventing excessive bleeding following vascular injury . On a molecular level, F3 functions as the high-affinity receptor for coagulation factor VII, forming a complex that initiates the coagulation protease cascades through specific limited proteolysis . Unlike other cofactors in the coagulation pathway that circulate as nonfunctional precursors, F3 is fully functional when expressed on cell surfaces . The protein features three distinct domains: extracellular, transmembrane, and cytoplasmic .

What are the structural and biochemical properties of commercially available Recombinant Bovine Tissue Factor?

Commercial Recombinant Bovine Tissue Factor preparations typically exhibit the following characteristics:

The protein's biochemical functions include cytokine receptor activity, phospholipid binding, and protease binding capabilities, contributing to its diverse roles in hemostasis and signaling pathways .

What are the recommended storage and reconstitution protocols for Recombinant Bovine Tissue Factor?

Proper handling of Recombinant Bovine Tissue Factor is essential for maintaining its activity and ensuring experimental reproducibility. Follow these evidence-based protocols:

Storage Recommendations:

• Upon receipt, store lyophilized protein at -80°C

• Reconstituted protein solution can be stored at 4°C for up to 1 week

• For long-term storage (up to 12 months), store reconstituted protein at -80°C in small aliquots

Reconstitution Protocol:

• Always centrifuge tubes before opening to ensure the lyophilized protein is at the bottom

• Reconstitute in 10mM PBS (pH 7.4) to a concentration of 0.1-1.0 mg/mL

• Avoid mixing by vortexing or vigorous pipetting; instead, gently invert or rotate the tube

• Aliquot the reconstituted solution into smaller volumes to minimize freeze-thaw cycles

Repeated freezing and thawing significantly diminish protein activity; therefore, researchers should prepare single-use aliquots whenever possible. When transitioning between storage temperatures, allow the protein to gradually equilibrate to minimize potential denaturation or aggregation.

How can researchers accurately measure Tissue Factor activity in experimental systems?

Several methodologies exist for quantifying Tissue Factor activity in research settings. The optimal approach depends on your specific experimental questions:

Functional Activity Assays:

• TF-dependent procoagulant activity assay: This method utilizes commercial kits such as the CY-QUANTTM MV-TF Activity Kit to measure TF-dependent Factor Xa generation .

  • Samples are incubated with either anti-TF (blocking monoclonal antibody) or negative control (non-blocking monoclonal antibody)

  • A mixture containing FVII, FX, and CaCl₂ is added to initiate the reaction

  • FXa generation is measured using a chromogenic substrate, and TF activity is calculated by reference to a standard curve generated using relipidated recombinant TF

• Calibrated Automated Thrombogram (CAT): Measures thrombin generation triggered by TF

Expression Analysis:

• qPCR for mRNA expression: Real-time RT-PCR can quantify TF mRNA expression levels in cells or tissues

• Western blotting: For protein-level detection and semi-quantification

• Flow cytometry: For cell surface expression analysis

For comparative studies, TF activity should be normalized using appropriate housekeeping genes or proteins, and multiple technical and biological replicates should be included to ensure statistical validity.

What cell models are most appropriate for studying Bovine Tissue Factor in vitro?

The selection of cellular models depends on the specific research questions being addressed. Based on current literature, the following cell systems are commonly used for Bovine Tissue Factor research:

When selecting cellular models, researchers should consider:

• Expression levels: Different cell types express varying baseline levels of Tissue Factor

• Response characteristics: Cells differ in their response to stimuli like cytokines or inflammatory mediators

• Species compatibility: For co-culture or interaction studies, consider species-specific protein-protein interactions

For advanced studies, primary cells isolated from bovine tissues often provide more physiologically relevant data than immortalized cell lines, though they present greater technical challenges in maintenance and consistency.

How is Recombinant Bovine Tissue Factor utilized in inflammatory response research?

Recombinant Bovine Tissue Factor has emerged as a valuable tool in studying the intersection between coagulation and inflammation. Recent research has demonstrated that beyond its canonical role in hemostasis, Tissue Factor significantly impacts inflammatory signaling pathways:

• Cytokine induction studies: Experimental evidence shows that treating cells like HTR8 (trophoblast cells) with recombinant S-protein increases expression of pro-inflammatory cytokines including IL-1β and IL-6, with observable dose-dependent effects . Researchers can similarly design experiments using Recombinant Bovine Tissue Factor to investigate its effects on cytokine production.

• Experimental approach: Typically, cells are cultured to confluence, then exposed to different concentrations of Recombinant Bovine Tissue Factor (e.g., 10, 100, 1000 ng/ml) for 24 hours . Post-treatment analysis includes:

  • qPCR measurement of inflammatory markers (IL-1β, IL-6, IL-8)

  • Assessment of chemokine expression (CCL2, CCL5, CXCL9, CXCL10)

  • Protein-level confirmation via ELISA or Western blotting

• Pathway analysis: Studies can be enhanced by including pathway inhibitors to elucidate the specific signaling mechanisms through which Tissue Factor mediates inflammatory responses. Common pathways of interest include NF-κB, MAPK, and JAK-STAT signaling cascades .

This research direction is particularly relevant for understanding conditions characterized by dysregulated coagulation and inflammation, such as sepsis, atherosclerosis, and pregnancy complications.

What are the current applications of Recombinant Bovine Tissue Factor in coagulation research?

Recombinant Bovine Tissue Factor serves as a critical reagent in multiple aspects of coagulation research:

• Standardization and calibration: Used to establish reference curves for coagulation assays, particularly those measuring extrinsic pathway function .

• Comparative biology studies: Enables investigation of species-specific differences in coagulation cascades, which is valuable for developing animal models of human coagulation disorders.

• Complex formation analysis: Used to study the interaction between Tissue Factor and Factor VII, which initiates the extrinsic coagulation pathway . This complex provides a catalytic event responsible for initiating coagulation protease cascades through specific limited proteolysis.

• Microparticle and extracellular vesicle (EV) research: Applied in studying TF-positive EVs, which are increasingly recognized as important mediators in coagulation disorders, cancer progression, and inflammation .

How does Tissue Factor contribute to non-hemostatic cellular functions and signaling pathways?

Beyond its well-established role in coagulation, Tissue Factor participates in numerous non-hemostatic functions through its cytoplasmic domain and interaction with various signaling molecules:

• Cell signaling: Tissue Factor's cytoplasmic domain engages in signal transduction pathways affecting:

  • Cell migration and adhesion

  • Angiogenesis and vascular development

  • Cell survival and proliferation

• Inflammation modulation: TF contributes to inflammatory responses by:

  • Regulating pro-inflammatory cytokine production (IL-1β, IL-6, IL-8)

  • Influencing chemokine expression (CCL2, CCL5, CXCL9, CXCL10)

  • Modulating cellular responses to inflammatory stimuli like IFNγ

• Tissue remodeling and repair: TF signaling impacts:

  • Fibroblast activation and extracellular matrix production

  • Wound healing processes

  • Tissue development and regeneration

Research approach: Investigators can isolate these non-hemostatic functions experimentally by:

• Using mutated versions of Recombinant Bovine Tissue Factor with altered coagulant activity but intact signaling capacity

• Employing specific inhibitors that target either the coagulant or signaling functions

• Studying TF in conditions where coagulation is separately inhibited

This expanding understanding of TF biology opens new research avenues for therapeutic targeting in inflammation, cancer, and vascular disorders.

What are common challenges when working with Recombinant Bovine Tissue Factor and their solutions?

Researchers commonly encounter several technical issues when working with Recombinant Bovine Tissue Factor. Here are evidence-based solutions:

For troubleshooting activity-specific issues, researchers should always centrifuge tubes before opening, avoid mixing by vortexing or pipetting, reconstitute in 10mM PBS (pH 7.4) to a concentration of 0.1-1.0 mg/mL, and aliquot the reconstituted solution to minimize freeze-thaw cycles .

How should researchers interpret variations in Tissue Factor expression across different experimental models?

Interpreting variations in Tissue Factor expression requires careful consideration of multiple factors:

• Baseline expression differences:

  • Different cell types naturally express varying levels of Tissue Factor

  • For example, HTR8 and PMVECs show measurable expression of inflammatory markers in response to stimuli, while JEG3 cells may show different patterns (e.g., undetectable IL-1β and IL-8)

  • These differences represent normal biological variation rather than experimental error

• Response to stimuli:

  • Dose-dependent responses to treatments should be evaluated systematically

  • In published studies, increasing concentrations of stimuli (e.g., 10, 100, 1000 ng/ml) show corresponding increases in expression of certain markers like IL-1β and IL-6 in some cell types

  • The absence of response in certain cell lines may reflect biological specificity rather than technical failure

• Validation approaches:

  • Cross-validate expression findings using multiple techniques (qPCR, Western blot, activity assays)

  • Compare relative changes rather than absolute values when comparing across models

  • Consider normalized expression (relative to housekeeping genes) rather than raw expression data

• Statistical analysis:

  • Apply appropriate statistical tests for your experimental design

  • Report both statistical significance and effect size

  • Consider biological significance beyond statistical significance

What standardization methods ensure reproducible results when measuring Tissue Factor activity?

Ensuring reproducible Tissue Factor activity measurements requires rigorous standardization:

• Reference standards incorporation:

  • Include a standard curve using relipidated recombinant Tissue Factor of known activity

  • Maintain consistent lot numbers of reference materials when possible

  • Calibrate against international standards when available

• Assay validation protocols:

  • Determine the linear range, limit of detection, and variability of your assay

  • Validate specificity using blocking antibodies (e.g., anti-TF monoclonal antibodies)

  • Calculate TF-dependent activity by subtracting activity in the presence of blocking antibodies from total activity

• Controls implementation:

  • Include positive controls (samples with known TF activity)

  • Use negative controls (samples without TF or with TF activity blocked)

  • Run internal quality control samples across different experimental batches

• Methodological consistency:

  • Maintain consistent incubation times and temperatures

  • Standardize sample preparation methods

  • Use the same reagent lots when possible throughout a study

• Data normalization strategies:

  • For cellular experiments, normalize to cell number or protein content

  • For tissue samples, use consistent tissue weight or volume

  • Consider using housekeeping genes for qPCR normalization

By implementing these standardization practices, researchers can significantly improve the reproducibility and reliability of their Tissue Factor activity measurements, facilitating meaningful comparisons across different studies and experimental conditions.

What are promising new applications of Recombinant Bovine Tissue Factor in biomedical research?

Emerging research areas for Recombinant Bovine Tissue Factor include:

• Infectious disease models: Following findings that SARS-CoV-2 S-protein can induce Tissue Factor expression in various cell types, Recombinant Bovine Tissue Factor is being used to study coagulation dysregulation in infectious diseases . This provides insights into the coagulopathy observed in severe infections.

• Extracellular vesicle (EV) research: Studying TF-positive EVs as biomarkers for various pathological conditions, including cancer progression and thrombotic disorders . Recombinant Bovine Tissue Factor serves as an important control and calibrator in these studies.

• Comparative biology: Using bovine models to understand evolutionary conservation of coagulation mechanisms across species, which helps identify fundamental versus species-specific aspects of coagulation biology .

• Biomaterial development: Exploiting the pro-coagulant properties of Tissue Factor for developing hemostatic biomaterials for surgical applications and wound healing.

• Signalome mapping: Comprehensive characterization of Tissue Factor-induced signaling pathways beyond traditional coagulation cascades, advancing our understanding of its role in inflammation, angiogenesis, and cell survival .

These emerging applications highlight the versatility of Recombinant Bovine Tissue Factor as a research tool beyond its classical role in coagulation studies.

How can researchers optimize experimental design when studying Tissue Factor in complex biological systems?

Optimizing experimental design for Tissue Factor research in complex systems requires careful consideration of multiple factors:

• System complexity assessment:

  • Evaluate which components of your biological system might influence TF expression or activity

  • Consider interactions between coagulation, inflammation, and cell signaling pathways

  • Account for potential feedback loops between these systems

• Experimental controls hierarchy:

  • Include pathway-specific positive and negative controls

  • Use TF-deficient or TF-blocking conditions as functional controls

  • Consider time-course experiments to capture dynamic changes

• Multiparametric analysis approach:

  • Assess multiple readouts simultaneously (e.g., TF activity, cytokine production, signaling pathway activation)

  • Utilize technologies like multiplex cytokine assays or phosphoprotein arrays

  • Correlate functional outcomes with molecular changes

• Translational relevance enhancement:

  • Design experiments that bridge in vitro findings with in vivo observations

  • Consider physiologically relevant concentrations and conditions

  • When possible, validate findings in primary cells or tissues

• Statistical power and reproducibility planning:

  • Conduct power analyses to determine appropriate sample sizes

  • Pre-specify primary and secondary outcomes

  • Plan for independent experimental replication

By implementing these design principles, researchers can develop more robust experimental approaches that account for the complex biological context in which Tissue Factor functions, leading to more reliable and translationally relevant findings.